Evidence map›Paper›PMID 34833979›Full record

ArticleMolecules (Basel, Switzerland)2021

Cascade Transformations of 1-R-Ethynyl-9,10-anthraquinones with Amidines: Expanding Access to Isoaporphinoid Alkaloids.

Sergey Francevich Vasilevsky, Ol'ga Leonidovna Krivenko, Irina Vasilievna Sorokina, Dmitry Sergeevich Baev, Tatyana Genrikhovna Tolstikova, Igor V Alabugin

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sergey Francevich VasilevskyV.V. Voevodsky Institute of Chemical Kinetics and Combustion, Siberian Branch of the Russian Academy of Science, 630090 Novosibirsk, Russia.
Ol'ga Leonidovna KrivenkoV.V. Voevodsky Institute of Chemical Kinetics and Combustion, Siberian Branch of the Russian Academy of Science, 630090 Novosibirsk, Russia.
Irina Vasilievna SorokinaN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 prosp. Acad. Lavrent'eva, 630090 Novosibirsk, Russia.ORCID 0000-0002-2054-1467
Dmitry Sergeevich BaevN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 prosp. Acad. Lavrent'eva, 630090 Novosibirsk, Russia.ORCID 0000-0002-1795-9256
Tatyana Genrikhovna TolstikovaN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 prosp. Acad. Lavrent'eva, 630090 Novosibirsk, Russia.
Igor V AlabuginDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.ORCID 0000-0001-9289-3819
Novosibirsk Institute of Organic Chemistry · RUInstitute of Chemical Kinetics and Combustion · RUFlorida State University · US

Funding

Russian Foundation for Basic Research 16-03-00589
6 · The paper itself

Abstract

The interaction of acetamidine and phenylamidine with peri-R-ethynyl-9,10-anthraquinones in refluxing n-butanol leads to the formation of cascade transformations products: addition/elimination/cyclization-2-R-7

Indexed as

AlkaloidsAmidinesAnimalsAnthraquinonesAnti-Inflammatory AgentsAntineoplastic AgentsCell Line, TumorChemistry Techniques, SyntheticHumansMaleMiceMice, Inbred C57BLMolecular Docking SimulationQuinolines9,10-anthraquinoneAlkaloidsAmidinesAnthraquinonesAnti-Inflammatory AgentsAntineoplastic AgentsQuinolines2-R-7H-dibenzo[de,h]quinolin-7-onesalkynesamidinesanti-inflammatory activitycyclization

Identifiers

PMID34833979
PMCPMC8621605
OpenAlexW3213629455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.